Phase II trial of gemcitabine in patients with advanced sarcomas (E1797):A trial of the Eastern Cooperative Oncology GroupOKUNO, Scott; RYAN, Louise M; EDMONSON, John H et al.Cancer. 2003, Vol 97, Num 8, pp 1969-1973, issn 0008-543X, 5 p.Article

Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapyALLWEIS, Tanir M; BOISVERT, Marc E; OTERO, Susan E et al.The American journal of surgery. 2002, Vol 183, Num 3, pp 218-221, issn 0002-9610Article

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical ModelCHUGH, Rashmi; KYLE WATHEN, J; SAMUELS, Brian L et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3148-3153, issn 0732-183X, 6 p.Article

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomasMAKI, Robert G; WATHEN, J. Kyle; THALL, Peter F et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2755-2763, issn 0732-183X, 9 p.Article

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) TrialCHUGH, Rashmi; WATHEN, J. Kyle; BENJAMIN, Robert S et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4884-4891, issn 1078-0432, 8 p.Article